Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 33

Publication Record

Connections

Hydroxycarbamide and white matter integrity in pediatric sickle cell disease: Commentary to accompany: Hydroxycarbamide treatment in children with sickle cell anaemia is associated with more intact white matter integrity: a quantitative MRI study.
Lance EI, Jordan LC
(2019) Br J Haematol 187: 141-143
MeSH Terms: Anemia, Sickle Cell, Antisickling Agents, Child, Humans, Hydroxyurea, Magnetic Resonance Imaging, White Matter
Added March 24, 2020
0 Communities
1 Members
0 Resources
7 MeSH Terms
Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial.
Abdullahi SU, DeBaun MR, Jordan LC, Rodeghier M, Galadanci NA
(2019) Pediatr Neurol 95: 73-78
MeSH Terms: Adolescent, Anemia, Sickle Cell, Antisickling Agents, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Hydroxyurea, Infant, Male, Nigeria, Prospective Studies, Recurrence, Secondary Prevention, Stroke
Added March 24, 2020
0 Communities
1 Members
0 Resources
16 MeSH Terms
Fertility challenges for women with sickle cell disease.
Ghafuri DL, Stimpson SJ, Day ME, James A, DeBaun MR, Sharma D
(2017) Expert Rev Hematol 10: 891-901
MeSH Terms: Anemia, Sickle Cell, Blood Transfusion, Chronic Pain, Female, Fertility, Fertility Preservation, Genetic Therapy, Hematopoietic Stem Cell Transplantation, Humans, Hydroxyurea, Infertility, Pregnancy, Primary Ovarian Insufficiency, Reproductive Health, Transplantation Conditioning
Added November 9, 2018
0 Communities
1 Members
0 Resources
MeSH Terms
Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).
Galadanci NA, Umar Abdullahi S, Vance LD, Musa Tabari A, Ali S, Belonwu R, Salihu A, Amal Galadanci A, Wudil Jibir B, Bello-Manga H, Neville K, Kirkham FJ, Shyr Y, Phillips S, Covert BV, Kassim AA, Jordan LC, Aliyu MH, DeBaun MR
(2017) Am J Hematol 92: 780-788
MeSH Terms: Anemia, Sickle Cell, Antisickling Agents, Child, Child, Preschool, Female, Follow-Up Studies, Hospitalization, Humans, Hydroxyurea, Incidence, Male, Medication Adherence, Nigeria, Reproducibility of Results, Sensitivity and Specificity, Stroke, Treatment Outcome, Ultrasonography, Doppler, Transcranial
Added April 27, 2017
0 Communities
3 Members
0 Resources
18 MeSH Terms
Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia.
Ghafuri DL, Chaturvedi S, Rodeghier M, Stimpson SJ, McClain B, Byrd J, DeBaun MR
(2017) Pediatr Blood Cancer 64:
MeSH Terms: Adolescent, Anemia, Sickle Cell, Antisickling Agents, Blood Flow Velocity, Cerebrovascular Circulation, Child, Child, Preschool, Cohort Studies, Female, Humans, Hydroxyurea, Male, Retrospective Studies, Ultrasonography, Doppler, Transcranial
Added January 2, 2017
0 Communities
2 Members
0 Resources
14 MeSH Terms
New option for primary stroke prevention in sickle cell anaemia.
DeBaun MR, Kirkham FJ
(2016) Lancet 387: 626-627
MeSH Terms: Anemia, Sickle Cell, Antisickling Agents, Blood Transfusion, Female, Humans, Hydroxyurea, Male
Added July 20, 2016
0 Communities
1 Members
0 Resources
7 MeSH Terms
Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
Chaturvedi S, DeBaun MR
(2016) Am J Hematol 91: 5-14
MeSH Terms: Adult, Anemia, Sickle Cell, Anti-Bacterial Agents, Antibiotic Prophylaxis, Antisickling Agents, Blood Transfusion, Child, Child, Preschool, Chronic Disease, Hematopoietic Stem Cell Transplantation, Humans, Hydroxyurea, Infant, Infant, Newborn, Mortality, Neonatal Screening, Penicillins, Stroke
Added December 16, 2015
0 Communities
2 Members
0 Resources
18 MeSH Terms
Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
Galadanci NA, Abdullahi SU, Tabari MA, Abubakar S, Belonwu R, Salihu A, Neville K, Kirkham F, Inusa B, Shyr Y, Phillips S, Kassim AA, Jordan LC, Aliyu MH, Covert BV, DeBaun MR
(2015) Pediatr Blood Cancer 62: 395-401
MeSH Terms: Anemia, Sickle Cell, Antisickling Agents, Child, Child, Preschool, Feasibility Studies, Female, Follow-Up Studies, Guideline Adherence, Humans, Hydroxyurea, Male, Middle Cerebral Artery, Nigeria, Pilot Projects, Stroke, Ultrasonography, Doppler, Transcranial
Added March 19, 2015
1 Communities
3 Members
0 Resources
16 MeSH Terms
Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review.
DeBaun MR
(2014) Expert Rev Hematol 7: 767-73
MeSH Terms: Anemia, Sickle Cell, Animals, Antisickling Agents, Humans, Hydroxyurea, Hypogonadism, Infertility, Male, Male, Spermatogenesis
Added October 7, 2014
1 Communities
1 Members
0 Resources
9 MeSH Terms
The challenge of creating an evidence-based guideline for sickle cell disease.
DeBaun MR
(2014) JAMA 312: 1004-5
MeSH Terms: Anemia, Sickle Cell, Blood Transfusion, Humans, Hydroxyurea
Added October 7, 2014
1 Communities
1 Members
0 Resources
4 MeSH Terms